The Venture Codex Logo

The Venture Codex

Overview

Novel sublingual tablets for procedural sedation and analgesia.

Total Raised

$35 M

Rounds

2

Links

Verticals

Health Care
Health Diagnostics
Pharmaceutical

Investment History

  1. Series B

    Apr 2024

    $24M

  2. Series A

    Feb 2019

    $11M

Team

Mark L. Baum

Founder

Brad Osborne

Chief Financial Officer

Giovanni DeCastro

Operations